Literature DB >> 11306274

Integrin-associated protein (CD47) and its ligands.

E J Brown1, W A Frazier.   

Abstract

Integrin-associated protein (IAP or CD47) is a receptor for thrombospondin family members, a ligand for the transmembrane signaling protein SIRP alpha and a component of a supramolecular complex containing specific integrins, heterotrimeric G proteins and cholesterol. Peptides containing a VVM motif in the C-terminal domain of thrombospondins are agonists for CD47, initiating heterotrimeric Gi protein signaling that augments the functions of integrins of the beta 1, beta 2 and beta 3 families, thus modulating a range of cell activities including platelet activation, cell motility and adhesion, and leukocyte adhesion, migration and phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306274     DOI: 10.1016/s0962-8924(00)01906-1

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  290 in total

1.  A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

Authors:  Maria E Bamberger; Meera E Harris; Douglas R McDonald; Jens Husemann; Gary E Landreth
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

Review 2.  Macrophages as mediators of tumor immunosurveillance.

Authors:  Siddhartha Jaiswal; Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Trends Immunol       Date:  2010-05-07       Impact factor: 16.687

3.  Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47.

Authors:  Sukhbir Kaur; Gema Martin-Manso; Michael L Pendrak; Susan H Garfield; Jeff S Isenberg; David D Roberts
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

4.  CD47-dependent molecular mechanisms of blood outgrowth endothelial cell attachment on cholesterol-modified polyurethane.

Authors:  Masako Ueda; Ivan S Alferiev; Stacey B Simons; Robert P Hebbel; Robert J Levy; Stanley J Stachelek
Journal:  Biomaterials       Date:  2010-06-09       Impact factor: 12.479

5.  CD47-deficient mice have decreased production of intestinal IgA following oral immunization but a maintained capacity to induce oral tolerance.

Authors:  Jessica Westlund; Megan Livingston; Linda Fahlén-Yrlid; Per-Arne Oldenborg; Ulf Yrlid
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

6.  Signal regulatory protein α regulates the homeostasis of T lymphocytes in the spleen.

Authors:  Miho Sato-Hashimoto; Yasuyuki Saito; Hiroshi Ohnishi; Hiroko Iwamura; Yoshitake Kanazawa; Tetsuya Kaneko; Shinya Kusakari; Takenori Kotani; Munemasa Mori; Yoji Murata; Hideki Okazawa; Carl F Ware; Per-Arne Oldenborg; Yoshihisa Nojima; Takashi Matozaki
Journal:  J Immunol       Date:  2011-06-01       Impact factor: 5.422

7.  Role of the CD47-SHPS-1 system in regulation of cell migration.

Authors:  Sei-Ichiro Motegi; Hideki Okazawa; Hiroshi Ohnishi; Ryuji Sato; Yoriaki Kaneko; Hisae Kobayashi; Kyoko Tomizawa; Tomokazu Ito; Nakayuki Honma; Hans-Jörg Bühring; Osamu Ishikawa; Takashi Matozaki
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

8.  Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42.

Authors:  Motoaki Miyashita; Hiroshi Ohnishi; Hideki Okazawa; Hiroyasu Tomonaga; Akiko Hayashi; Tetsuro-Takahiro Fujimoto; Nobuhiko Furuya; Takashi Matozaki
Journal:  Mol Biol Cell       Date:  2004-06-23       Impact factor: 4.138

9.  Mechanical control of cAMP signaling through integrins is mediated by the heterotrimeric Galphas protein.

Authors:  Francis J Alenghat; Jessica D Tytell; Charles K Thodeti; Alexandrine Derrien; Donald E Ingber
Journal:  J Cell Biochem       Date:  2009-03-01       Impact factor: 4.429

10.  Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Yong Wook Park; Young Mo Kang; Joe Butterfield; Michael Detmar; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.